The DNMT3A mutation results in the accumulation of cells in the bone marrow due to impaired differentiation [19], while ASXL1 is crucial in the pathogenesis of leukemia by altering histone modifications and increasing the risk of transformation to MDS [20]. Here, DNMT3A is linked to leukemia.